Colon Cancer Genomic Mapping May Point Toward Therapies

The largest study of colon cancer tumors to date found new mutations that may cause malignancy in various organs, bolstering research that links the disease more to specific genetic changes than its location in the body.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.